TrialAutopsyBuilt by Jawad Momani (Pwnedl0l)

Autopsy report · NCT01037959

Norfloxacin Therapy for Patients With Cirrhosis and Severe Liver Failure

Cause of deathSlow enrollment Automatic label, confidence 0.9, unverified. How labels are made.
“lack of recruitement”

The sponsor’s own words in the registry.

Life of this trial

20092010201120122013201420152016Registered2009-12-21Started2010-04Primary completion2014-11Stopped2015-11

Vital statistics

Status
Terminated
Phase
Phase 3
Sponsor
Assistance Publique - Hôpitaux de Paris
Sponsor type
University, hospital or other
Conditions
Cirrhosis
Interventions
Norfloxacin; Placebo
Participants
291
Sites
1
Countries
France

Trials that died the same way

Look deeper

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.